Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-06
DOI
10.3389/fnagi.2018.00263
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model
- (2018) Guido N. Vacano et al. NEUROBIOLOGY OF AGING
- A Noradrenergic Lesion Exacerbates Neurodegeneration in a Down Syndrome Mouse Model
- (2018) Jason Lockrow et al. JOURNAL OF ALZHEIMERS DISEASE
- Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Enhances Tau Expression
- (2018) Wei Qian et al. JOURNAL OF ALZHEIMERS DISEASE
- 6-Hydroxydopamine induces brain vascular endothelial inflammation
- (2017) Qizhi Fu et al. IUBMB LIFE
- Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models
- (2017) Alain D. Dekker et al. NEUROBIOLOGY OF DISEASE
- Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment
- (2017) Alessandro Stefani et al. NEUROCHEMISTRY INTERNATIONAL
- Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
- (2017) Igor Cervenka et al. SCIENCE
- Solid Malignancies in Individuals With Down Syndrome: A Case Presentation and Literature Review
- (2017) Scott V. Bratman et al. Journal of the National Comprehensive Cancer Network
- Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer’s disease: An autopsy-confirmed study
- (2017) Satoru Morimoto et al. PLoS One
- Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease
- (2016) Ai-Ling Lin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Increases of SET level and translocation are correlated with tau hyperphosphorylation at ser202/thr205 in CA1 of Ts65Dn mice
- (2016) Emilie Dorard et al. NEUROBIOLOGY OF AGING
- Trisomy 21 consistently activates the interferon response
- (2016) Kelly D Sullivan et al. eLife
- Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome
- (2015) Eric D. Hamlett et al. Current Alzheimer Research
- Morbidity and medication in a large population of individuals with Down syndrome compared to the general population
- (2015) Myriam Alexander et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
- (2015) Arlan Richardson et al. EXPERIMENTAL GERONTOLOGY
- A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
- (2015) Frances K. Wiseman et al. NATURE REVIEWS NEUROSCIENCE
- Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
- (2015) Jennifer M. Parrott et al. Frontiers in Psychiatry
- Risk of Major Cardiovascular Events in People with Down Syndrome
- (2015) Christopher G. Sobey et al. PLoS One
- Haematopoietic development and leukaemia in Down syndrome
- (2014) Irene Roberts et al. BRITISH JOURNAL OF HAEMATOLOGY
- Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: Report from the Italian Cooperative Group for Neuroblastoma
- (2014) Sebastiano Barco et al. CLINICAL BIOCHEMISTRY
- Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism
- (2014) Lucile Capuron et al. CURRENT PHARMACEUTICAL DESIGN
- Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease
- (2014) Yannick Vermeiren et al. NEUROBIOLOGY OF AGING
- Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive
- (2013) Dudley W. Lamming et al. AGING CELL
- Late-life rapamycin treatment reverses age-related heart dysfunction
- (2013) James M. Flynn et al. AGING CELL
- Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes
- (2013) S. Malinge et al. BLOOD
- Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
- (2013) Yimin Fang et al. Cell Metabolism
- Atypical aging in down syndrome
- (2013) Warren B. Zigman Developmental Disabilities Research Reviews
- The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease
- (2013) Marta Amaral et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Current Estimate of Down Syndrome Population Prevalence in the United States
- (2013) Angela P. Presson et al. JOURNAL OF PEDIATRICS
- Tryptophan metabolism: entering the field of aging and age-related pathologies
- (2013) Annemieke T. van der Goot et al. TRENDS IN MOLECULAR MEDICINE
- Alterations in metabolic pathways and networks in Alzheimer’s disease
- (2013) R Kaddurah-Daouk et al. Translational Psychiatry
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis
- (2012) Marcia H. Tanaka et al. CYTOKINE
- The Critical Role of Metabolic Pathways in Aging
- (2012) N. Barzilai et al. DIABETES
- Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls
- (2012) Markus J. Schwarz et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival
- (2012) Alejo Efeyan et al. NATURE
- Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
- (2012) J. Halloran et al. NEUROSCIENCE
- MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis
- (2012) J. Xia et al. NUCLEIC ACIDS RESEARCH
- Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling
- (2011) Smita Majumder et al. AGING CELL
- Antioxidants in Down syndrome
- (2011) Ira T. Lott BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn
- (2011) Laura G. Reinholdt et al. MAMMALIAN GENOME
- Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome
- (2011) Arnaud Duchon et al. MAMMALIAN GENOME
- Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging
- (2011) David Patterson et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Resistance exercise enhances mTOR and MAPK signalling in human muscle over that seen at rest after bolus protein ingestion
- (2010) D. R. Moore et al. Acta Physiologica
- Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006
- (2010) Samantha E. Parker et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
- (2010) Ivana Bjedov et al. Cell Metabolism
- Neural Stem Cells Reduce Hippocampal Tau and Reelin Accumulation in Aged Ts65Dn down Syndrome Mice
- (2010) D. S. Kern et al. CELL TRANSPLANTATION
- Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
- (2010) V. P. Houde et al. DIABETES
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
- (2010) Antonella Caccamo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapamycin Protects against Neuron Death in In Vitro andIn Vivo Models of Parkinson's Disease
- (2010) C. Malagelada et al. JOURNAL OF NEUROSCIENCE
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
- (2010) Shomit Sengupta et al. MOLECULAR CELL
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
- (2010) M. T. Heneka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulation of the Norepinephrine Transporter Sustains Cortical Hypodopaminergia and Schizophrenia-Like Behaviors in Neuronal Rictor Null Mice
- (2010) Michael A. Siuta et al. PLOS BIOLOGY
- Does the learning deficit observed under an incremental repeated acquisition schedule of reinforcement in Ts65Dn mice, a model for Down syndrome, change as they age?
- (2009) Nichole C. Sanders et al. BEHAVIOURAL BRAIN RESEARCH
- The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
- (2009) Hiroyuki Mori et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A systems biology approach to Down syndrome: Identification of Notch/Wnt dysregulation in a model of stem cells aging
- (2009) C.J. Cairney et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome
- (2009) A. Contestabile et al. CELL PROLIFERATION
- Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model
- (2009) Jennifer H. K. Choi et al. JOURNAL OF NEUROCHEMISTRY
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
- Immune Regulation by Rapamycin: Moving Beyond T Cells
- (2009) M. R. Janes et al. Science Signaling
- The Pharmacology of mTOR Inhibition
- (2009) D. A. Guertin et al. Science Signaling
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Hematopoietic defects in the Ts1Cje mouse model of Down syndrome
- (2008) C. L. Carmichael et al. BLOOD
- Cell Cycle Elongation Impairs Proliferation of Cerebellar Granule Cell Precursors in the Ts65Dn Mouse, an Animal Model for Down Syndrome
- (2008) Andrea Contestabile et al. BRAIN PATHOLOGY
- Assessment of post-mortem-induced changes to the mouse brain proteome
- (2008) Stephen W. Hunsucker et al. JOURNAL OF NEUROCHEMISTRY
- Survival in Elderly Persons with Down Syndrome
- (2008) Antonia M. W. Coppus et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Biphasic Response of Pancreatic -Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice
- (2008) Y. Shigeyama et al. MOLECULAR AND CELLULAR BIOLOGY
- In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
- (2008) Yuanxin Chen et al. NEUROBIOLOGY OF AGING
- Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ?
- (2008) Thomas J. Connor et al. NEUROSCIENCE LETTERS
- Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease
- (2008) Gianluigi Lunardi et al. PARKINSONISM & RELATED DISORDERS
- Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome
- (2007) G. Kirsammer et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now